Fact sheet: Carnegie Medical

Fund information

Fund name
Carnegie Medical 1A EUR
Fund company manager
Carnegie Asset Management
Fund type
SIB
Fund manager
Angelica Fatouros
since 01/07/2008
Fund objective
The investment objective of the C WorldWide Medical fund is to achieve long term capital growth by investing globally in a limited number of companies within the healthcare sector. Most of the investments are in the major pharmaceutical companies, but also in smaller and medium-sized companies.
Benchmark
MSCI World Healthcare
Investment style
Growth
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

1.02 %

1 Year rank in sector

26/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 523.6 m

FE Risk score

156

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • North America
    76.2%
  • Continental Europe
    20.9%
  • UK
    2.9%
  • Pharmaceuticals
    41.6%
  • Biotechnology/Medical
    39.1%
  • Services
    19.3%
  • North American Equities
    76.2%
  • European Equities
    20.9%
  • UK Equities
    2.9%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-0.7 %4.78 %1.02 %26.81 %80.04 %
Sector1.98 %12.69 %10.38 %31.15 %105.72 %
Rank within sector21 / 3026 / 2926 / 2916 / 2619 / 23
Quartile th3 rd4 th4 th3 rd4 th

Calendar performance

YTD-20172016201520142013
Fund7.1 %-14.37 %10.68 %38.82 %31.94 %
Sector15.76 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector23 / 2920 / 299 / 275 / 2416 / 23
Quartile th4 th3 rd2 nd1 st3 rd

Risk statistics

Alpha-1.13
Beta1.13
Sharpe0.24
Volatility18.88
Tracking error7.14
Information ratio-0.06
R-Squared0.87

Price movement

52 week high101.85
52 week low82.43
Current bid price0
Current offer price0
Current mid price96.81

Holdings by region

  • 76.2% North America
  • 20.9% Continental Europe
  • 2.9% UK

Holdings by sector

  • 41.6% Pharmaceuticals
  • 39.1% Biotechnology/Medical
  • 19.3% Services

Holdings by asset type

  • 76.2% North American Equities
  • 20.9% European Equities
  • 2.9% UK Equities

Individual holdings

  • 6.2% UNITEDHEALTH GROUP INC
  • 6.1% JOHNSON & JOHNSON
  • 4.7% GILEAD SCIENCES INC
  • 4.4% C WORLDWIDE MEDICAL SMALL & MID CAP
  • 4.1% ACTAVIS INC
  • 3.9% CELGENE CORP
  • 3.7% ROCHE HLDG AG
  • 3.4% AMGEN INC
  • 3% PFIZER INC
  • 2.9% GENMAB AS